Review
Jul 2026
EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.
This review provides a comprehensive overview of EGFR biology, its signaling pathways, and strategies for therapeutic targeting and explores fourth-generation TKIs and allosteric inhibitors alongside newer treatment strategies, such as PROTACs, combination immunotherapy, and precision medicine methods.
Amna Tamimi, Mantasha Khan, M. K. A. Khan et al.
· Current Medicinal Chemistry · 0 citations